Thai Ha Co., Limited
⚠️ Moderate Risk
FEI: 3004310216 • Sam Phran, Nakhon Pathom • THAILAND
FEI Number
3004310216
Location
Sam Phran, Nakhon Pathom
Country
THAILANDAddress
140 Moo 5, Tumbol Bahggratuk, Amphur Sampran, Sam Phran, Nakhon Pathom, Thailand
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
FILTHY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.
LIST INGRE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.
LACKS N/C
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/4/2022 | 02AGT99GRAIN, WHOLE, N.E.C. | 75UNAPPROVED | Division of West Coast Imports (DWCI) |
| 12/30/2019 | 04YGT03BEAN THREAD | Division of Northern Border Imports (DNBI) | |
| 12/30/2019 | 04YGT03BEAN THREAD | Division of Northern Border Imports (DNBI) | |
| 9/29/2014 | 02DGT02RICE, PLAIN (WHITE OR POLISHED) PROCESSED (PACKAGED) | 249FILTHY | Division of Northeast Imports (DNEI) |
| 9/29/2014 | 02DGT02RICE, PLAIN (WHITE OR POLISHED) PROCESSED (PACKAGED) | 249FILTHY | Division of Northeast Imports (DNEI) |
| 9/29/2014 | 02DGT02RICE, PLAIN (WHITE OR POLISHED) PROCESSED (PACKAGED) | 249FILTHY | Division of Northeast Imports (DNEI) |
| 9/29/2014 | 02DGT02RICE, PLAIN (WHITE OR POLISHED) PROCESSED (PACKAGED) | 249FILTHY | Division of Northeast Imports (DNEI) |
Frequently Asked Questions
What is Thai Ha Co., Limited's FDA import refusal history?
Thai Ha Co., Limited (FEI: 3004310216) has 7 FDA import refusal record(s) in our database, spanning from 9/29/2014 to 4/4/2022.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Thai Ha Co., Limited's FEI number is 3004310216.
What types of violations has Thai Ha Co., Limited received?
Thai Ha Co., Limited has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Thai Ha Co., Limited come from?
All FDA import refusal data for Thai Ha Co., Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.